<?xml version="1.0" encoding="utf-8"?><sys><loid>3.0.1206198777</loid><uuid>6e08abbc-01d6-11e8-8ba7-cdc29d688b6b</uuid><path>/Production/LesEchos/Articles/PME Regions/Innovateurs/INNOV Vaxinano.xml</path><name>INNOV Vaxinano.xml</name><description/><type>EOM::CompoundStory</type><owner>chouzelle</owner><creator>chouzelle</creator><timeCreated>1516888111</timeCreated><lastModifier>chouzelle</lastModifier><timeModified>1517418012</timeModified><locker/><timeLocked>1517418012</timeLocked><statusName>LE-Articles-Redaction/Mise en ligne</statusName><statusIdentifier>RGB(243,2,252)</statusIdentifier><size>4196</size><updateCounter>467</updateCounter><props><workFolder>/Redaction/PME-REGIONS/Innovateurs</workFolder><productInfo><name>LEC-Redaction</name><issueDate>20180129</issueDate></productInfo><templateName>/SysConfig/LesEchos/HorsPage/Templates/Article_swing.xml</templateName><process><type>spelling</type><user>lsala</user></process><summary>Nicole BuyseCorrespondante à Lille Le professeur Didier Betbeder (à gauche) et Vincent Lemonnier (à droite) ont cofondé la société lilloise Vaxinano.DR Développant des vaccins sans adjuvant, administrés par voie nasale et 100 % bioéliminables, Vaxina</summary><charsCount>2401</charsCount><wordCount>367</wordCount><createdDate>20180125134831</createdDate><edSection>PME &amp; Regions</edSection></props><tl><t><id>2</id><tp>ExternalFileProxy</tp><c>chouzelle</c><cd>20180125134800</cd><dt><ip>10.70.51.179</ip><ts>1516888166564</ts><applicationId>Swing</applicationId></dt></t><t><id>26</id><tp>PrintLink</tp><c>mclement</c><cd>20180131150200</cd><dt><uid lid="U301230931445PQE" path="PME2 0102.pgl">2c04f244-0667-11e8-bf19-1dbe003e5157</uid><channel>LEC-Journal</channel><issueDate>20180201</issueDate><size>1842c/30L42</size><story><name>PME_INNOVATEUR-pied</name><type>Article Innovateurs</type></story></dt></t><t><id>27</id><tp>Export</tp><c>chouzelle</c><cd>20180131170000</cd><dt><channel>LEC-Redaction</channel><last>20180131180012</last></dt></t><t><id>28</id><tp>EOM::Status</tp><c>chouzelle</c><cd>20180131170000</cd><dt><status comment="Photo envoyée par mail"/></dt></t><t><id>30</id><tp>EOM::Task</tp><c>chouzelle</c><cd>20180131170000</cd><dt><task comment="Photo envoyée par mail" creator="chouzelle" priority="0" status="0" subject="INNOV Vaxinano" uuid="5758f1e2-01d6-11e8-8ba7-cdc29d688b6b"/></dt></t></tl><va xmlns:eom="http://www.eidosmedia.com/eom"><folder_size>1</folder_size><parent_uuid>2f524cee-2deb-11e2-b509-00144f465cc6</parent_uuid><oteam>Service_REGIONS-COLLECTIVITES</oteam><cteam>Service_REGIONS-COLLECTIVITES</cteam><vid>9</vid><vt>1517405880</vt></va></sys>